|
Mechanismβ1-adrenergic receptor antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date17 Dec 2007 |
Blutzucker-Nachtprofile Mit Wecker Und Selbstmessungen gegenüber Fremdmessungen Durch Spezialisiertes Pflegepersonal: Eine Analyse Mittels Kontinuierlichem Glukose-Monitoring (Glucoday®)
Study hypothesis: Waking up in response to an alarm clock may evoke a stress reaction that leads to rising glucose concentrations.
The purpose of this study was to prove this hypothesis with continuous glucose monitoring over three nights.
Night (a) with an alarm clock set at 2 h intervals for glucose self monitoring,
Night (b) with a nurse performing blood glucose determinations, and
Night (c) with the patients left undisturbed.
INFLUENCE OF NEBIVOLOL ON OCULAR PERFUSION IN PATIENTS WITH ARTERIAL HYPERTENSION AND GLAUCOMAA mono-center, active-substance controlled, randomized, double-blind, prospective phase IV parallel-group trial comparing Nebivolol with Bisoprolol - Influence of nebivolol on ocular perfusion in patients with arterial hypertension and glaucoma
EFFECTS OF NEBIVOLOL ON THE WALKING ABILITY IN PATIENTS WITH ESSENTIAL HYPERTENSION AND PERIPHERAL ARTERIAL DISEASE INTERMITTENT CLAUDICATION
100 Clinical Results associated with Berlin-Chemie/Menarini Pharma GmbH
0 Patents (Medical) associated with Berlin-Chemie/Menarini Pharma GmbH
100 Deals associated with Berlin-Chemie/Menarini Pharma GmbH
100 Translational Medicine associated with Berlin-Chemie/Menarini Pharma GmbH